Speaker illustration

Professor Gilles Lambert


Pr. Lambert is Professor in Cell Biology and Biochemistry at the University of La Réunion Medical School (France) and a group leader at Inserm UMR1188 DéTROI laboratory. He was awarded a PhD in Pathophysiology from the University of Paris. He specialized in lipidology, first as a post-doctoral fellow at the NIH (Bethesda MD) and then as a senior research fellow at the Heart Research Institute (Sydney, Australia). Pr. Lambert has conducted seminal research projects on PCSK9, a protein that targets the LDL receptor for intracellular degradation, and the target of novel cholesterol lowering agents. Pr. Lambert current research interests are to elucidate the specific role of PCSK9 in insulin producing beta-cells and to understand the cellular pathways by which PCSK9 modulates the circulating levels of lipoprotein (a), a highly atherogenic lipoprotein species.

PCSK9 inhibition: from biology to clinical applications.

Event: ESC Congress 2020

Topic: Pharmacology and Pharmacotherapy, Other

Session: Atherothrombosis: New Therapeutic Targets


PCSK9, the short track road from discovery as drug target towards the clinic.

Event: ESC Congress 2016

Topic: Lipids

Session: PCSK9 inhibition in clinical lipid management: a critical review of evidence and opportunities


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb